Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Patent
1997-05-20
1999-10-19
LeGuyader, John L.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
435 6, 435 911, 435325, 435366, 4353721, 435375, 435440, 536 231, 536 2431, 536 2433, 536 245, C12Q 168, C07H 2104
Patent
active
059688254
ABSTRACT:
The following description sets forth antisense (AS) oligonucleotides (ODNs) complementary to the primary transcript of the human c-fes protooncogene and their use to inactivate said transcript. All-trans retinoic acid (ATRA) is reported to be used as a differentiation inducer on cells pretreated with said AS-ODNs to induce apoptosis of leukemic blast cells.
REFERENCES:
Frankel et al., "The Retinoic Acid Syndrome in Acute Promyelocytic Leukemia", American College of Physicians, 1992, pp. 292-296.
Dubois et al., "Modulation of IL-8, IL-1.beta., and G-CSF Secretion by All-Trans Retinoic Acid in Acute Promyelocytic Leukemia", Leukemia, vol. 8, No. 10, Oct. 1994, pp. 1750-1757.
Grande et al., "All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells", Experimental Hematology, vol. 23, 1995, pp. 117-125.
Miller et al., "Anticode Oligonucleoside Methylphosphonates and Their Psoralen Derivatives", Antisense Research and Applications, 1993, pp. 189-203.
Citro et al., "Inhibition of leukemia cell proliferation by receptor-medicated uptake of c-myb antisense oligodeoxynucleotides", Proc. Natl. Acad. Sci., vol. 89, Aug. 1992, pp. 7031-7035.
Ferrari et al., "Expression of human c-fes onc-gene occurs at detectable levels in myeloid but not in lymphoid cell populations", British Journal of Haematology, 1985, vol. 59, pp. 21-25.
Castaigne et al., "All-Trans Retinoic Acid as a Differentiation Therapy for Acute Promyelocytic Leukemia. I. Clinical Results", Blood, vol. 76, No. 9, Nov. 1990, pp. 1704-1709.
Alcalay et al., "Characterization of human and mouse c-fes cDNA clones and identification of the 5' end of the gene", Oncogene, 1990, vol. 5, pp. 267-275.
Delva et al., "Resistance to All-Trans Retinoic Acid (ATRA) Therapy in Relapsing Acute Promyelocytic Leukemia: Study of In Vitro ATRA Sensitivity and Cellular Retinoic Acid Binding Protein Levels in Leukemic Cells", Blood, vol. 82, No. 7, Oct. 1993, pp. 2175-2181.
Ferrari et al., "Expression of the Myeloperoxidase Gene in Acute and Chronic Myeloid Leukemias: Relationship to the Expression of Cell Cycle-Related Genes", Leukemia, vol. 13, No. 6, Jun. 1989, pp. 423-430.
Ferrari et al., "Expression of Growth-regulated Genes in Human Acute Leukemias", Cancer Research 46, Oct. 1986, pp. 5162-5166.
Zeleznik-Le et al., "The Molecular Biology of Myeloproliferative Disorders as Revealed by Chromosomal Abnormalities", Seminars in Hematology, vol. 32, No. 3, Jul. 1995, pp. 201-219.
Ferrari et al. "Proliferation, Differentiation Arrest, and Survival in Leukemic Blast Cells", New York Academy of Sciences, vol. 663, Nov. 1992, pp. 202-214.
Gewirtz et al. PNAS 93:3161-3163 (1996).
Rojanasakul Adv. Drug Delivery Reviews 18(1996) 115-131.
Ferrari et al. Cell Growth and Differentiation 1:543-548, Nov. 1990.
Ferrari et al. Leukemia 8(Suppl. 1) 1994. 591-594.
Manfredini et al. Blood 89(1):135-145, Jan. 1, 1997.
Manfredini et al. J. Exp. Med. 178:381-389, Aug. 1993.
Ferrari et al. Proceedings Amer. Assoc. Cancer Res. 34. 1993. 94.
Ferrari Sergio
Manfredini Rossella
Istituto Biochimico Italiano Giovanni Lorenzini S.p.A.
LeGuyader John L.
LandOfFree
Antisense oligonucleotides complementary to the primary transcri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides complementary to the primary transcri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides complementary to the primary transcri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2054948